BioCryst Reports Second Quarter 2026 Financial Results
Go back to BioCryst Reports Second Quarter 2026 Financial Results| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.59 +0.07 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.52 | 52 Week High | $10.98 | |||
| Open | $8.52 | 52 Week Low | $1.63 | |||
| Day High | $8.63 | P/E | N/A | |||
| Day Low | $8.40 | EPS | $-0.68 | |||
| Volume | 3,666,726 | |||||

